ATE305794T1 - Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts - Google Patents

Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts

Info

Publication number
ATE305794T1
ATE305794T1 AT02702393T AT02702393T ATE305794T1 AT E305794 T1 ATE305794 T1 AT E305794T1 AT 02702393 T AT02702393 T AT 02702393T AT 02702393 T AT02702393 T AT 02702393T AT E305794 T1 ATE305794 T1 AT E305794T1
Authority
AT
Austria
Prior art keywords
producing
plant extract
extract containing
containing matrine
matrine
Prior art date
Application number
AT02702393T
Other languages
English (en)
Inventor
John Wah Tze
Peizhong Lin
Stephen Lam
Joseph Tai
Frisi Hobbe Smit
Helvoort Adrianus Lambertu Van
Robert Johan Joseph Hageman
Theresa P Chiang Tze
Original Assignee
Global Cancer Strategies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Cancer Strategies Ltd filed Critical Global Cancer Strategies Ltd
Application granted granted Critical
Publication of ATE305794T1 publication Critical patent/ATE305794T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fertilizers (AREA)
AT02702393T 2001-02-26 2002-02-26 Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts ATE305794T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/793,251 US20030099725A1 (en) 2001-02-26 2001-02-26 Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
PCT/EP2002/002350 WO2002067955A2 (en) 2001-02-26 2002-02-26 A process for the manufacture of a herbal composition comprising a matrine

Publications (1)

Publication Number Publication Date
ATE305794T1 true ATE305794T1 (de) 2005-10-15

Family

ID=25159475

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02702393T ATE305794T1 (de) 2001-02-26 2002-02-26 Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts
AT02711728T ATE304368T1 (de) 2001-02-26 2002-02-26 Kräuterpflanzen enthaltende artzneimittel
AT02711729T ATE397936T1 (de) 2001-02-26 2002-02-26 Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT02711728T ATE304368T1 (de) 2001-02-26 2002-02-26 Kräuterpflanzen enthaltende artzneimittel
AT02711729T ATE397936T1 (de) 2001-02-26 2002-02-26 Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen

Country Status (11)

Country Link
US (5) US20030099725A1 (de)
EP (4) EP1363651B1 (de)
JP (1) JP2004529885A (de)
CN (1) CN1585647A (de)
AT (3) ATE305794T1 (de)
AU (2) AU2002231544A1 (de)
CA (1) CA2439301A1 (de)
DE (3) DE60206474T2 (de)
DK (1) DK1370271T3 (de)
HK (2) HK1060694A1 (de)
WO (4) WO2002067961A2 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054592A1 (en) * 2002-12-13 2004-07-01 Gobind Prasad Dubey Herbal preparation for management of cardiovascular and neurologic disorders
US8668908B2 (en) * 2002-12-31 2014-03-11 National Yang-Ming University Method for alleviating chemotherapy side effects using extract of Dioscorea sp
US20060068036A1 (en) 2002-12-31 2006-03-30 National Yang-Ming University Extract of Dioscorea sp. and the medical uses thereof
GB0317020D0 (en) * 2003-07-21 2003-08-27 Sahajanand Biotech Private Ltd Herbo-mineral formulation for refractory leukemias and lymphomas
US20050025823A1 (en) * 2003-07-29 2005-02-03 Fong Andy A.T. Methods of use of herbal compositions
US20060008540A1 (en) * 2004-07-08 2006-01-12 Rulin Xiu Herbal compositions comprising portaluca
US20060024391A1 (en) * 2004-07-30 2006-02-02 Lak Zarahmehran S Dietary nutritional suppliments for persons smoking tobacco products
US7368133B2 (en) * 2004-08-23 2008-05-06 Yu Ching Wu Medicinal drug and methods of manufacturing the same
US7384657B2 (en) * 2004-10-14 2008-06-10 Jeffrey Young Composition of natural herb extract for treating cardiovascular disease and its method of preparation thereof
WO2006066354A1 (en) * 2004-12-24 2006-06-29 Dolphst Pty Ltd Formula ions and treatments for well-being
WO2007012335A1 (fr) * 2005-07-26 2007-02-01 Djamila Souiki Traitement de tout types de cancer, kystes, fibromes, des infections, inflammations, anxiete, migraines, desequilibre hormonal, ulcere, asthme, maladie de crohne, eczema, psoriasis, rhumatisme, acne.
CN100431581C (zh) * 2006-01-20 2008-11-12 丽珠医药集团股份有限公司 治疗禽流感的中药组合物、制备方法及其用途
US20070202215A1 (en) * 2006-02-28 2007-08-30 Zahramehran Salari Lak Dietary nutritional supplements for persons consuming alcohol products
WO2007132893A1 (ja) * 2006-05-17 2007-11-22 Arkray, Inc. Ｍｃｐ－１の発現抑制剤、それを用いた炎症性疾患の改善剤、医薬品、サプリメント、食品、飲料および食品添加剤
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
DE202008011721U1 (de) * 2008-09-03 2008-12-24 American Phoenix Biotech Inc., Hacienda Heights Pflanzliche Zusammensetzung zur Behandlung von Krebs
KR101103426B1 (ko) 2009-04-10 2012-01-09 영남대학교 산학협력단 몰루긴 또는 몰루긴 유도체를 유효성분으로 함유하는 염증성 장질환 치료용 약학조성물
US8535739B2 (en) * 2010-01-28 2013-09-17 George Lowe Sparkle essence system
KR20120080674A (ko) * 2011-01-08 2012-07-18 주식회사한국전통의학연구소 대계근 추출물을 포함하는 백혈병 치료용 조성물 및 건강 기능성 식품
CN102091049B (zh) * 2011-01-17 2015-12-02 广东东阳光药业有限公司 一种苦参碱分散片及其制备工艺
CN103127057A (zh) * 2011-11-25 2013-06-05 复旦大学 梣酮在制备抗肿瘤药物中的应用
CN102532147B (zh) * 2011-12-30 2014-05-21 山东省分析测试中心 高纯度白鲜碱单体的制备方法
CN102641454B (zh) * 2012-05-22 2014-01-01 江苏省中医药研究院 一种治疗慢性萎缩性胃炎的中药组合物
CN103630630B (zh) * 2013-12-16 2014-11-19 广西大学 一种山豆根药材中苦参碱的含量测定方法
CN104887834A (zh) * 2014-03-04 2015-09-09 苏州益福康材料科技有限公司 一种用于治疗或预防哺乳动物癌症和其他疾病的包含苦参碱的组合物
CN104887684A (zh) * 2014-03-07 2015-09-09 复旦大学 雅姆皂苷元在制备抗肿瘤药物中的应用
CN105250743A (zh) * 2015-09-17 2016-01-20 连艳芬 一种治疗肺癌中药
CN105769880B (zh) 2016-03-09 2018-05-15 广东省中医院 黄柏酮在制备防治肺损伤和肺纤维化的药物中的应用
CN106526057B (zh) * 2016-09-22 2017-12-05 广东东阳光药业有限公司 一种检测珠芽蓼中黄酮类成分的薄层色谱分析方法
CN112437660B (zh) * 2018-06-01 2024-06-14 耶鲁大学 治疗类固醇激素相关疾病或障碍的组合物和方法
CN108815435A (zh) * 2018-08-31 2018-11-16 陕西石宇药业有限公司 一种治疗瘙痒性皮肤病的中药组合物及其制剂的制备方法
CN110960668A (zh) * 2018-09-28 2020-04-07 上海市浦东新区浦南医院 一种用于预防和治疗肝病的组合物及其应用
KR102236022B1 (ko) * 2019-06-24 2021-04-05 계명대학교 산학협력단 사데풀 추출물을 유효성분으로 함유하는 피부 미백 또는 주름개선용 조성물
CN110354010A (zh) * 2019-07-24 2019-10-22 石家庄市中医院 一种具有抗幽门螺杆菌功效的漱口水
CN110297060B (zh) * 2019-07-25 2021-09-17 广西中医药大学 一种山苦荬药材指纹图谱检测方法及其指纹图谱
KR102093073B1 (ko) * 2019-08-30 2020-03-24 국립해양생물자원관 사데풀 추출물을 유효성분으로 함유하는 항염증용 조성물
US20230165923A1 (en) * 2020-03-17 2023-06-01 Epidarus Therapeutics, Llc Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof
CN111317734A (zh) * 2020-03-27 2020-06-23 广州医科大学附属第二医院 Wnt信号通路抑制剂和应用
KR102456184B1 (ko) * 2020-09-21 2022-10-18 국립해양생물자원관 사데풀 추출물을 유효성분으로 함유하는 비용종 질환 예방 또는 치료용 조성물
CN114246868B (zh) * 2021-12-24 2023-06-06 中国人民解放军军事科学院军事医学研究院 一种尿路感染病原体尿路致病性大肠杆菌的抑制剂
CN114271144A (zh) * 2021-12-31 2022-04-05 张宇希 一种杉树下种植南板蓝根的方法
CN114259488A (zh) * 2022-01-27 2022-04-01 杭州师范大学 中药分子梣酮在制备治疗神经胶质瘤药物上的应用
CN115192571A (zh) * 2022-07-11 2022-10-18 中国人民解放军总医院第五医学中心 化合物Rutaevin在制备治疗胃癌药物中的应用
CN115778888B (zh) * 2023-02-10 2023-04-28 云南云科特色植物提取实验室有限公司 一种白及提取物的制备方法及其产品和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
GB2226494B (en) * 1988-07-20 1991-10-09 Poon Theodore Man Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
CN1047975A (zh) * 1989-06-13 1990-12-26 李晨芙 一种抗癌药剂的配制方法
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
EP0665017A1 (de) * 1993-12-30 1995-08-02 Henne, Kurt Arzneimittel für die Tumorprophylaxe und -behandlung
CN1124092A (zh) * 1994-12-10 1996-06-12 王跃进 生命面粉
CN1125591A (zh) * 1994-12-28 1996-07-03 刘继先 胃平
JPH0912451A (ja) * 1995-06-30 1997-01-14 Terumo Corp 抗ヘリコバクター・ピロリ薬
CN1159340A (zh) * 1996-03-11 1997-09-17 李城林 一种抗癌抑瘤药物的配方及其制作工艺
CN1175458A (zh) * 1997-09-05 1998-03-11 张玉杰 治疗心脑血管疾病的中药
KR100239879B1 (ko) * 1997-11-05 2000-02-01 김상조 간암 예방 및 치료용 생약제
AU3734999A (en) * 1998-05-16 1999-12-06 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
CN1094367C (zh) * 1999-02-10 2002-11-20 徐守宏 一种治疗皮肤病、性病、妇科病的外用药
CN1176724C (zh) * 1999-07-13 2004-11-24 安得勋 婴儿用卫生材料中含有的中药组合物
CN1324657A (zh) * 1999-09-29 2001-12-05 马纯熙 治疗心脑血管病的中药制剂及其生产方法
DE10031651A1 (de) * 2000-06-29 2002-01-17 Schwabe Willmar Gmbh & Co Extrakte aus Sophora-Arten, Verfahren zu ihrer Herstellung und Verwendung

Also Published As

Publication number Publication date
EP1370271A2 (de) 2003-12-17
CN1585647A (zh) 2005-02-23
DE60206137D1 (de) 2005-10-20
ATE304368T1 (de) 2005-09-15
EP1363651B1 (de) 2005-09-14
JP2004529885A (ja) 2004-09-30
WO2002067960A1 (en) 2002-09-06
DE60206137T2 (de) 2006-07-27
HK1060694A1 (en) 2004-08-20
DE60206474D1 (de) 2005-11-10
US20050025841A1 (en) 2005-02-03
WO2002067961A2 (en) 2002-09-06
EP1392334B1 (de) 2008-06-11
US20040192579A1 (en) 2004-09-30
EP1370271B1 (de) 2005-10-05
US20060165816A1 (en) 2006-07-27
AU2002235930A1 (en) 2002-09-12
DE60206474T2 (de) 2006-07-13
CA2439301A1 (en) 2002-09-19
EP1370274A1 (de) 2003-12-17
WO2002067955A3 (en) 2002-11-07
EP1363651A1 (de) 2003-11-26
HK1061203A1 (en) 2004-09-10
WO2002067961A3 (en) 2003-05-15
US20030099725A1 (en) 2003-05-29
EP1392334A2 (de) 2004-03-03
WO2002072120A1 (en) 2002-09-19
DE60227068D1 (de) 2008-07-24
AU2002231544A1 (en) 2002-09-12
DK1370271T3 (da) 2006-02-20
WO2002067955A2 (en) 2002-09-06
US20040170704A1 (en) 2004-09-02
ATE397936T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
ATE305794T1 (de) Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts
ATE342270T1 (de) Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung
DE60120209D1 (de) Effiziente methode zur herstellung von zusammensetzungen, die mit anthocyaninen angereichert sind
WO2006015115A3 (en) Potent immunostimulatory extracts from microalgae
CY1108193T1 (el) Μεθοδος για την παραγωγη συνθεσεων που περιεχουν φλαβονοειδη και χρηση αυτων
EP1707238A4 (de) Pharmazeutika aus der traditionellen chinesischen medizin zur behandlung von lungenkrebs und herstellungsverfahren dafür
BR0108564A (pt) Preparações cosméticas contendo extratos vegetais
CN104873431A (zh) 一种保健精油
MY137752A (en) Medicament for treating aseptic inflammations containing anemonin as effective component
AU2003216884A1 (en) Plant extracts and the use thereof
WO2007024510A3 (en) Medicinal herbal composition for treating infection
WO2003030822A3 (en) Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
DE60331999D1 (de) Hautaufhellende zusammensetzung
WO2002062952A3 (en) Non-cytotoxic pap mutants
DK1331939T3 (da) Murraya koenigii-ekstrakter til behandling af astma
KR20120119933A (ko) 자연산 생약물질과 프로폴리스 추출물을 이용한 구강 청결 및 구취 제거제
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
DE50103561D1 (de) Verfahren zur herstellung von phyllanthusextrakten
ATE271876T1 (de) Verwendung einer synergistischen zusammensetzung zur herstellung eines medikaments zur behandlung von lebererkrankungen
NZ512525A (en) Skin whitening compositions for oral administration comprising a solvent extract from the plant of the genus Rosaceae Pyracantha
WO2006005219A8 (fr) Composition pharmaceutique pour traiter la depression, et procede pour la preparer
DE60020888D1 (de) Zusatz aus kräutern zur behandlung von kognitiven störungen aufgrund von östrogenverlust
BR9805069A (pt) Processo de preparação e uso de isoflavonas.
MY142178A (en) Use of anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies
UA72887C2 (uk) Противиразковий репаративний засіб "ріфлан"

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1370271

Country of ref document: EP

REN Ceased due to non-payment of the annual fee